Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
Authors:
Open Access
- 6 November 2019
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (1) , 40-49
Abstract
Liver diseases caused by viral infection, alcohol abuse and metabolic disorders can progress to end‐stage liver failure, liver cirrhosis and liver cancer, which are a growing cause of death worldwide. Although liver transplantation and hepatocyte transplantation are useful strategies to promote liver regeneration, they are limited by scarce sources of organs and hepatocytes. Mesenchymal stem cells (MSCs) restore liver injury after hepatogenic differentiation and exert immunomodulatory, anti‐inflammatory, antifibrotic, antioxidative stress and antiapoptotic effects on liver cells in vivo. After isolation and culture in vitro, MSCs are faced with nutrient and oxygen deprivation, and external growth factors maintain MSC capacities for further applications. In addition, MSCs are placed in a harsh microenvironment, and anoikis and inflammation after transplantation in vivo significantly decrease their regenerative capacity. Pre‐treatment with chemical agents, hypoxia, an inflammatory microenvironment and gene modification can protect MSCs against injury, and pre‐treated MSCs show improved hepatogenic differentiation, homing capacity, survival and paracrine effects in vitro and in vivo in regard to attenuating liver injury. In this review, we mainly focus on pre‐treatments and the underlying mechanisms for improving the therapeutic effects of MSCs in various liver diseases. Thus, we provide evidence for the development of MSC‐based cell therapy to prevent acute or chronic liver injury. Mesenchymal stem cells have potential as a therapeutic to prolong the survival of patients with end‐stage liver diseases in the near future.Keywords
Funding Information
- National Natural Science Foundation of China (81700553)
- China Postdoctoral Science Foundation (2017M183789)
This publication has 76 references indexed in Scilit:
- Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinomaCarcinogenesis, 2013
- Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal TransitionPLOS ONE, 2012
- Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissuesJournal of Gastroenterology and Hepatology, 2012
- Efficacy of Mesenchymal Stem Cells in Suppression of Hepatocarcinorigenesis in Rats: Possible Role of Wnt SignalingJournal of Experimental & Clinical Cancer Research, 2011
- Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Hepatic Ischemia Reperfusion Injury in a Rat ModelPLOS ONE, 2011
- Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?Stem Cells, 2010
- Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cellsCell Communication and Signaling, 2010
- Systems approaches to preventing transplanted cell death in cardiac repairJournal of Molecular and Cellular Cardiology, 2008
- Immunomodulation of activated hepatic stellate cells by mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2007
- Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment In VivoPLOS ONE, 2007